218
Participants
Start Date
March 3, 2021
Primary Completion Date
March 3, 2025
Study Completion Date
March 3, 2033
Toripalimab
Toripalimab: 240 mg, intravenous injection over 60 minutes (Q3W); Toripalimab should be completed for 2 cycles at 1-2 weeks before surgery, and continually applied since 1-2 weeks after surgery until confirmed disease progression, death, unacceptable toxicity, withdrawal of consent, investigator decision, or 1 year.
salvage surgery
Endoscopic nasopharyngectomy is used for recurrent nasopharyngeal tumor and selective neck dissection for recurrent regional lymph node.
NOT_YET_RECRUITING
The Tenth Affiliated Hospital, Sun Yat-Sen University, Nanchang
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
NOT_YET_RECRUITING
The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou
NOT_YET_RECRUITING
Nanfang Hospital of Southern Medical University, Guangzhou
NOT_YET_RECRUITING
The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou
NOT_YET_RECRUITING
The First People's Hospital of Foshan, Guangzhou
NOT_YET_RECRUITING
Zhongshan People's Hospital, Zhongshan
First Affiliated Hospital, Sun Yat-Sen University
OTHER
Nanfang Hospital, Southern Medical University
OTHER
First People's Hospital of Foshan
OTHER
Zhongshan People's Hospital, Guangdong, China
OTHER
Tenth Affiliated Hospital, Sun Yat-sen University
UNKNOWN
Sun Yat-sen University
OTHER